WKN DE: A427CB / ISIN: US59564R8723

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Biodexa Pharmaceuticals Times and Sales (NAS)

Zeit	Kurs	Umsatz (Stk)	Umsatz grafisch
Times and Sales Zur Zeit stehen keine Daten zur Verfügung

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Biodexa Pharmaceuticals PLC (spons. ADRs)

Weitere Meldungen

04:11		Strait of Hormuz ship transits are rising thanks to US help
04:11		Strait of Hormuz ship transits are rising thanks to US help
04:00		This Quantum Computing Stock Is the One the Smart Money Doesn't Want You to Find
03:33		Move Over, Nvidia: 1 AI Stock Just Posted Its Best Day Since 2011 -- and Wall Street Says It's Still Cheap.
03:23		A Penguin Solutions Director Sold 12,000 Company Shares. Here's What That Means for Investors.
03:09		This One Social Security Rule Changes at Full Retirement Age
02:59		IMSA: BMW M Team WRT setzt Podiumsserie fort - Platz zwei für Philipp Eng und Marco Wittmann in Detroit.
02:41		1 Thing Investors Should Know About Meta's New Subscription Strategy
02:39		Oscar Health vs. UnitedHealth: Which Healthcare Stock Is a Better Buy in 2026?
02:18		SpaceX Wants Even More Profits Ahead of Its IPO
01:37		Can Starlink Make American Airlines a Winner?
01:00		Every Big Tech Company Is Solving AI the Same Way. This Stock Is Solving It Differently.
00:41		The Dividend ETF Built for Whatever the Market Does Next
00:23		Ferrari wanted to take on Chinese EVs with the Luce - then the backlash started
00:00		Can You Live Without Social Security for 1 Month? Here's How That Could Pay Off Big Time.
30.05.26		SK Hynix Just Hit a $1 Trillion Market Cap. Here's How You Can Buy the Stock for Around $60.
30.05.26		Time to Diversify Internationally?
30.05.26		Datadog Share Value Has More Than Doubled As Investors Recognize a Growing Market Opportunity
30.05.26		Thriving in the Age of Overwhelm
30.05.26		Why This Fund Dumped $35 Million of UiPath Even as Revenue Grew 17%
30.05.26		'The Legend of Vox Machina,' 'Every Year After' and More New Prime Video Releases We're Watching in June
30.05.26		Nio's Battery Swap Network Just Delivered 16% of All EV Energy in China in 5 Days. Is the Market Sleeping on This?
30.05.26		Pitney Bowes CEO Sells Company Shares Worth $3.8 Million. What Does That Mean for Investors?
30.05.26		RXO Stock Has Surged 75% Since This Fund Made a $10 Million Bet
30.05.26		Give Your Family the Gift of an Estate Plan
30.05.26		Brookfield Is Combining Its Insurance Arm With the Parent Company. Here's What It Means for Investors.
30.05.26		SpaceX IPO Nears and Retail Makes a Comeback
30.05.26		Stop Trying to Beat the Market: This Vanguard ETF Outperforms 90% of Professional Fund Managers
30.05.26		NASA And UFO ETFs Are Surging Ahead Of SpaceX IPO But Key Risks Remain
30.05.26		Why One Real Estate Fund Dumped $62 Million of Cousins Properties Stock
30.05.26		Is Privia Health Stock a Buy After Hedge Fund Rubicon Founders Added Over 175,000 Shares to Its Position?
30.05.26		Today's Wordle Hints, Answer and Help for May 31, #1807
30.05.26		What to Know About This Fund's $74.8 Million Indivior Sale
30.05.26		Is It Smart to Claim Social Security Early When the Stock Market Is Volatile? Here Are the Pros and Cons.
30.05.26		Wealth Manager Sells $7 Million of Establishment Labs After Massive Gains. Is This Medical Device Stock a Buy?
30.05.26		1 Overlooked Reason to Buy Amazon Stock Right Now
30.05.26		Paris Saint-Germain retain Champions League with victory over Arsenal
30.05.26		Dang Van Phuoc Dies at 90; Intrepid Photojournalist in Vietnam War
30.05.26		These Artificial Intelligence (AI) Stocks Have Crushed Nvidia in 2026 With Gains of 67% and 121%. They Can Still Soar Higher
30.05.26		Should You Buy SpaceX Stock After the Starship V3 Megarocket Launch?
30.05.26		Bloom Energy vs. Plug Power: Which Hydrogen Stock Is a Better Buy in 2026?
30.05.26		Is This AI Stock a Buy After Dropping 20% From Its All-Time High?
30.05.26		Why a Fund Made a $143 Million Bet on Indivior With Shares Up a Staggering 200%
30.05.26		Why This Fund Made a $30 Million Bet on Floor & Decor Amid a 30% Stock Drop
30.05.26		Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More
30.05.26		SoftBank pledges €75bn to build Europe’s biggest AI facility in France
30.05.26		Arm vs. Qualcomm: Consistent Growth vs. Revenue Volatility
30.05.26		SpaceX Holds $1.5 Billion in Bitcoin. Does That Make the Coin a Buy?
30.05.26		Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial
30.05.26		1 AI Stock That Could Turn $500 per Month Into $1 Million

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Semantix Incorporation Registered Shs SKK a Cheer BWL MOZAYYX Acquisition a

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	31.05.2026 04:47
Kaufwert:	EUR
	Hinzufügen Speichern

Biodexa Pharmaceuticals Aktie

WKN DE: A427CB / ISIN: US59564R8723

Biodexa Pharmaceuticals Times and Sales (NAS)

Times and Sales

Analysen zu Biodexa Pharmaceuticals PLC (spons. ADRs)

Weitere Meldungen